Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Levra MG"'
Autor:
Hatat AS; Team 'RNA Splicing, Cell Signaling and Response to Therapies', Institute for Advanced Biosciences (IAB), INSERM U1209, CNRS UMR 5309, Grenoble Alpes University, France., Benoit-Pilven C; Laboratory of Biology and Modelling of the Cell, Univ Lyon, ENS de Lyon, Univ Claude Bernard, CNRS UMR 5239, INSERM U1210, Lyon, France., Pucciarelli A; Team 'RNA Splicing, Cell Signaling and Response to Therapies', Institute for Advanced Biosciences (IAB), INSERM U1209, CNRS UMR 5309, Grenoble Alpes University, France., de Fraipont F; Team 'RNA Splicing, Cell Signaling and Response to Therapies', Institute for Advanced Biosciences (IAB), INSERM U1209, CNRS UMR 5309, Grenoble Alpes University, France.; Molecular Genetic Unit, Grenoble-Alpes University Hospital, France., Lamothe L; Team 'RNA Splicing, Cell Signaling and Response to Therapies', Institute for Advanced Biosciences (IAB), INSERM U1209, CNRS UMR 5309, Grenoble Alpes University, France., Perron P; Team 'RNA Splicing, Cell Signaling and Response to Therapies', Institute for Advanced Biosciences (IAB), INSERM U1209, CNRS UMR 5309, Grenoble Alpes University, France., Rey A; Laboratory of Biology and Modelling of the Cell, Univ Lyon, ENS de Lyon, Univ Claude Bernard, CNRS UMR 5239, INSERM U1210, Lyon, France., Levra MG; Team 'RNA Splicing, Cell Signaling and Response to Therapies', Institute for Advanced Biosciences (IAB), INSERM U1209, CNRS UMR 5309, Grenoble Alpes University, France.; Thoracic Oncology Unit, Grenoble-Alpes University Hospital, France., Toffart AC; Team 'RNA Splicing, Cell Signaling and Response to Therapies', Institute for Advanced Biosciences (IAB), INSERM U1209, CNRS UMR 5309, Grenoble Alpes University, France.; Thoracic Oncology Unit, Grenoble-Alpes University Hospital, France., Auboeuf D; Laboratory of Biology and Modelling of the Cell, Univ Lyon, ENS de Lyon, Univ Claude Bernard, CNRS UMR 5239, INSERM U1210, Lyon, France., Eymin B; Team 'RNA Splicing, Cell Signaling and Response to Therapies', Institute for Advanced Biosciences (IAB), INSERM U1209, CNRS UMR 5309, Grenoble Alpes University, France., Gazzeri S; Team 'RNA Splicing, Cell Signaling and Response to Therapies', Institute for Advanced Biosciences (IAB), INSERM U1209, CNRS UMR 5309, Grenoble Alpes University, France.
Publikováno v:
Molecular oncology [Mol Oncol] 2022 Oct; Vol. 16 (19), pp. 3490-3508. Date of Electronic Publication: 2022 Aug 30.
Autor:
Bilger G; Medical Oncology, Institut Curie, Saint Cloud, France. bilger.geoffroy@gmail.com., Girard N; Institut du Thorax Curie-Montsouris, Institut Curie, Paris, France., Doubre H; Thoracic Oncology, Hopital Foch, Suresnes, France., Levra MG; Thoracic Oncology Unit, CHU Grenobles Alpes, La Tronche, France., Giroux-Leprieur E; Respiratory Diseases and Thoracic Oncology, Hopital Ambroise Pare, Boulogne Billancourt, France., Giraud F; Pneumo-Oncology, Hôpital Cochin, Paris, France., Decroisette C; Respiratory Diseases and Thoracic Oncology, Le Centre Hospitalier Annecy Genevois, Metz-Tessy, France., Carton M; Unit of Biometry, Institut Curie, DRCI, PSL Research University, Paris, France., Massiani MA; Medical Oncology, Institut Curie, Saint Cloud, France.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 Jul; Vol. 71 (7), pp. 1719-1731. Date of Electronic Publication: 2021 Nov 25.
Autor:
Benet J; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France. Electronic address: jbenet@chu-grenoble.fr., Toffart AC; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France; Institute for Advanced Biosciences INSERM U1209 CNRS UMR5309 Université Grenoble Alpes, Grenoble, France., Brichon PY; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France., Chollier T; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France., Ruckly S; ICUREsearch, Paris, France., Villa J; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France., Emprou C; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France; Institute for Advanced Biosciences INSERM U1209 CNRS UMR5309 Université Grenoble Alpes, Grenoble, France., Pierret T; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France., Dumas I; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France., Ferretti G; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France; Institute for Advanced Biosciences INSERM U1209 CNRS UMR5309 Université Grenoble Alpes, Grenoble, France., Moro-Sibilot D; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France; Institute for Advanced Biosciences INSERM U1209 CNRS UMR5309 Université Grenoble Alpes, Grenoble, France., Levra MG; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, 38700 France; Institute for Advanced Biosciences INSERM U1209 CNRS UMR5309 Université Grenoble Alpes, Grenoble, France.
Publikováno v:
Cancer treatment and research communications [Cancer Treat Res Commun] 2022; Vol. 30, pp. 100508. Date of Electronic Publication: 2022 Jan 04.
Autor:
Gheerbrant H; Department of Pneumology and Physiology, Grenoble-Alpes University Hospital, BP217, FR-38043, Grenoble Cedex 9, France. hgheerbrant@chu-grenoble.fr., Timsit JF; Medical and Infectious Diseases ICU, APHP, Paris, France.; Department of Biostatistics, OUTCOMEREA™, Bobigny, France., Terzi N; Department of Intensive Care and Reanimation, Grenoble-Alpes University Hospital, Grenoble, France.; INSERM, U1042, Grenoble-Alpes University Hospital, HP2, Grenoble, France., Ruckly S; Department of Biostatistics, OUTCOMEREA™, Bobigny, France., Laramas M; Cancer and Blood Diseases, Grenoble-Alpes University Hospital, Grenoble, France., Levra MG; Department of Pneumology and Physiology, Grenoble-Alpes University Hospital, BP217, FR-38043, Grenoble Cedex 9, France., Jacquet E; Cancer and Blood Diseases, Grenoble-Alpes University Hospital, Grenoble, France., Falque L; Department of Pneumology and Physiology, Grenoble-Alpes University Hospital, BP217, FR-38043, Grenoble Cedex 9, France., Moro-Sibilot D; Department of Pneumology and Physiology, Grenoble-Alpes University Hospital, BP217, FR-38043, Grenoble Cedex 9, France., Toffart AC; Department of Pneumology and Physiology, Grenoble-Alpes University Hospital, BP217, FR-38043, Grenoble Cedex 9, France.; Institute for Advanced Biosciences - INSERM U823 - Grenoble-Alpes University, Grenoble, France.
Publikováno v:
BMC cancer [BMC Cancer] 2021 Jan 05; Vol. 21 (1), pp. 9. Date of Electronic Publication: 2021 Jan 05.
Autor:
Gobbini E; CHU de Grenoble, Thoracic Oncology Unit, Grenoble, France; Cancer Research Center Lyon, Centre Léon-Bérard, Lyon, France. Electronic address: elisa.gobbini@hotmail.it., Charles J; Institute for Advanced Biosciences, Université Grenoble Alpes/INSERM U1209/CNRS UMR 5309 Joint Research Center, Grenoble, France; Grenoble Alpes University Hospital, Dermatology Department, Grenoble, France., Toffart AC; CHU de Grenoble, Thoracic Oncology Unit, Grenoble, France., Leccia MT; Grenoble Alpes University Hospital, Dermatology Department, Grenoble, France., Moro-Sibilot D; CHU de Grenoble, Thoracic Oncology Unit, Grenoble, France., Levra MG; CHU de Grenoble, Thoracic Oncology Unit, Grenoble, France.
Publikováno v:
Bulletin du cancer [Bull Cancer] 2020 Nov; Vol. 107 (11), pp. 1098-1107. Date of Electronic Publication: 2020 Oct 05.
Autor:
Assié JB; Service de Pneumologie, CHI Créteil, UPEC, Créteil, France., Corre R; Service de Pneumologie, Centre Hospitalier Intercommunal de Quimper, Quimper, France., Levra MG; Thoracic Oncology Unit, Centre Hospitalier Universitaire Grenoble Alpes (CHUGA), Grenoble, France., Calvet CY; Bristol Myers Squibb France, Rueil-Malmaison, France., Gaudin AF; Bristol Myers Squibb France, Rueil-Malmaison, France., Grumberg V; Pharmacy Faculty Université Grenoble Alpes, Grenoble, France., Jouaneton B; HEVA, Lyon, France., Cotté FE; Bristol Myers Squibb, Rueil-Malmaison, France., Chouaïd C; Service de Pneumologie, CHI Créteil, UPEC, Créteil, France.
Publikováno v:
Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2020 Oct 26; Vol. 12, pp. 1758835920967237. Date of Electronic Publication: 2020 Oct 26 (Print Publication: 2020).
Autor:
Gobbini E; Thoracic Oncology Unit, CHU Grenoble-Alpes, Grenoble 38700, France.; Univ Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon 69373, France., Swalduz A; Department of Medical Oncology, Centre Léon Bérard, Lyon 69373, France., Levra MG; Thoracic Oncology Unit, CHU Grenoble-Alpes, Grenoble 38700, France., Ortiz-Cuaran S; Univ Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon 69373, France., Toffart AC; Thoracic Oncology Unit, CHU Grenoble-Alpes, Grenoble 38700, France., Pérol M; Department of Medical Oncology, Centre Léon Bérard, Lyon 69373, France., Moro-Sibilot D; Thoracic Oncology Unit, CHU Grenoble-Alpes, Grenoble 38700, France., Saintigny P; Univ Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon 69373, France.; Department of Medical Oncology, Centre Léon Bérard, Lyon 69373, France.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Oct 24; Vol. 12 (11). Date of Electronic Publication: 2020 Oct 24.
Autor:
Gobbini E; Thoracic Oncology Unit SHUPP, CHU Grenoble-Alpes, Grenoble, France; Cancer Research Center Lyon, Center Léon Bérard, Lyon, France. Electronic address: EGobbini@chu-grenoble.fr., Toffart AC; Thoracic Oncology Unit SHUPP, CHU Grenoble-Alpes, Grenoble, France., Pérol M; Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France., Assié JB; Thoracic Oncology Unit, CHU Créteil, Paris, France., Duruisseaux M; Unité de Recherche Commune en Oncologie Thoracique (URCOT), Hospices Civils de Lyon Cancer Institute, Lyon, France; Anticancer Antibodies Laboratory, Cancer Research Center of Lyon, Inserm 1052, CNRS 5286, Lyon, France; Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France., Coupez D; Thoracic Oncology Unit, CHU Nantes, Nantes, France., Dubos C; Thoracic Oncology Unit, Center François Baclesse, Caen, France., Westeel V; Thoracic Oncology Unit, CH Besançon, Besançon, France., Delaunay M; Pulmonology Department, CHU Toulouse, Toulouse, France., Guisier F; Pneumology, Thoracic Oncology, and Respiratory Intensive Care Unit, CHU Rouen, Rouen, France., Veillon R; Respiratory Diseases Department, F-33000, CHU Bordeaux, Bordeaux, France., Gounant V; Thoracic Oncology Department, CIC 1425 INSERM, Center Bichat, Paris, France., Giroux Leprieur E; Department of Respiratory Diseases and Thoracic Oncology, APHP-Hôpital Ambroise Pare, Paris, France., Vanel FR; Thoracic Oncology Unit, CHU Strasbourg, Strasbourg, France., Chaabane N; Pulmonology Service, AP-HP Paris Center University Hospitals, Cochin Hospital, Paris, France., Dansin E; Thoracic Oncology Unit, Center Oscar Lambret, Lille, France., Babey H; Thoracic Oncology Unit, CHRU Brest, Brest, France., Decroisette C; Pulmonology and Thoracic Oncology Unit, CH Annecy-Genevois, Annecy, France., Barlesi F; Aix-Marseille Université, CNRS, INSERM, CRCM, APHM, Marseille, France., Daniel C; Thoracic Oncology Unit, Institute Curie, Paris/Saint Cloud, France., Fournel P; Medical Oncology Department, Institut de Cancérologie de la Loire, Saint, France., Mezquita L; Department of Medical Oncology, Thoracic Group, Gustave Roussy, Villejuif, France., Oulkhouir Y; Pulmonology and Thoracic Oncology Unit, CHU Caen, Caen, France., Canellas A; Pulmonology Unit, APHP Hôpital Tenon and GRC 04 Theranoscan Sorbonne University, Paris, France., Duchemann B; Thoracic Oncology Unit, Center Bobigny, Paris, France., Molinier O; Thoracic Oncology Unit, CH Le Mans, Le Mans, France., Alcazer V; Cancer Research Center Lyon, Center Léon Bérard, Lyon, France., Moro-Sibilot D; Thoracic Oncology Unit SHUPP, CHU Grenoble-Alpes, Grenoble, France., Levra MG; Thoracic Oncology Unit SHUPP, CHU Grenoble-Alpes, Grenoble, France.
Publikováno v:
Clinical lung cancer [Clin Lung Cancer] 2020 Sep; Vol. 21 (5), pp. e497-e510. Date of Electronic Publication: 2020 May 08.
Autor:
Basse C; Institut du thorax Curie Montsouris, institut Curie, Paris, France., Swalduz A; Centre Léon-Bérard, département d'oncologie médicale, Lyon, France., Levra MG; CHU de Grenoble-Alpes, oncologie thoracique SHUPP, CS10217 cedex, 38043 Grenoble, France; Hospital HM Delfos, HM Hospitales, Centro Integral Oncológico Clara-Campal (HM-CIOCC), Department of Medical Oncology, Barcelona, Espagne; Université Grenoble-Alpes, Institute for Advanced Biosciences, Inserm U1209 CNRS UMR5309, Grenoble, France., Girard N; Institut du thorax Curie Montsouris, institut Curie, Paris, France., Remon J; Hospital HM Delfos, HM Hospitales, Centro Integral Oncológico Clara-Campal (HM-CIOCC), Department of Medical Oncology, Barcelona, Espagne., Moro-Sibilot D; CHU de Grenoble-Alpes, oncologie thoracique SHUPP, CS10217 cedex, 38043 Grenoble, France. Electronic address: DMoro.pneumo@chu-grenoble.fr.
Publikováno v:
Bulletin du cancer [Bull Cancer] 2020 Jul - Aug; Vol. 107 (7-8), pp. 779-791. Date of Electronic Publication: 2020 Jun 10.
Autor:
Lattuca-Truc M; Thoracic Oncology Unit, Grenoble-Alpes University Hospital, Grenoble, France., Timsit JF; Department of Biostatistics, OUTCOMEREA™, Bobigny, France., Levra MG; Thoracic Oncology Unit, Grenoble-Alpes University Hospital, Grenoble, France., Ruckly S; Department of Biostatistics, OUTCOMEREA™, Bobigny, France., Villa J; Radiotherapy Unit, Grenoble-Alpes University Hospital, Grenoble, France., Dumas I; Cancer Coordination Center, Grenoble-Alpes University Hospital, Grenoble, France., Pinsolle J; Thoracic Oncology Unit, Grenoble-Alpes University Hospital, Grenoble, France., Ferrer L; Thoracic Oncology Unit, Grenoble-Alpes University Hospital, Grenoble, France., Guillem P; Cancer Coordination Center, Grenoble-Alpes University Hospital, Grenoble, France., Moro-Sibilot D; Thoracic Oncology Unit, Grenoble-Alpes University Hospital, Grenoble, France., Toffart AC; Thoracic Oncology Unit, Grenoble-Alpes University Hospital, Grenoble, France; Institute for Advanced Biosciences, Grenoble, France. Electronic address: AToffart@chu-grenoble.fr.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2019 May; Vol. 131, pp. 122-127. Date of Electronic Publication: 2019 Mar 27.